MX2016015153A - Complementacion de microbioma neonatal. - Google Patents
Complementacion de microbioma neonatal.Info
- Publication number
- MX2016015153A MX2016015153A MX2016015153A MX2016015153A MX2016015153A MX 2016015153 A MX2016015153 A MX 2016015153A MX 2016015153 A MX2016015153 A MX 2016015153A MX 2016015153 A MX2016015153 A MX 2016015153A MX 2016015153 A MX2016015153 A MX 2016015153A
- Authority
- MX
- Mexico
- Prior art keywords
- fetus
- microbiome
- neonate
- probiotic microorganism
- administered
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title abstract 7
- 230000009469 supplementation Effects 0.000 title 1
- 210000003754 fetus Anatomy 0.000 abstract 4
- 239000006041 probiotic Substances 0.000 abstract 4
- 230000000529 probiotic effect Effects 0.000 abstract 4
- 235000018291 probiotics Nutrition 0.000 abstract 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 210000000214 mouth Anatomy 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462000842P | 2014-05-20 | 2014-05-20 | |
| PCT/EP2015/061181 WO2015177246A2 (en) | 2014-05-20 | 2015-05-20 | Neonatal microbiome supplementation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016015153A true MX2016015153A (es) | 2017-03-07 |
Family
ID=53284210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016015153A MX2016015153A (es) | 2014-05-20 | 2015-05-20 | Complementacion de microbioma neonatal. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170216375A1 (https=) |
| EP (1) | EP3145520A2 (https=) |
| JP (1) | JP2017515881A (https=) |
| KR (1) | KR20170005806A (https=) |
| CN (1) | CN106879253A (https=) |
| AU (1) | AU2015261869A1 (https=) |
| CL (1) | CL2016002732A1 (https=) |
| MX (1) | MX2016015153A (https=) |
| WO (1) | WO2015177246A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
| ES2870425T3 (es) * | 2014-10-29 | 2021-10-27 | Biogaia Ab | Uso de L. reuteri para la prevención o el tratamiento de la disbiosis de microbiota en la vida temprana |
| WO2019118984A2 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| CN112236513B (zh) | 2018-07-24 | 2023-09-19 | 生命大地女神有限公司 | 选择和使用褪黑素支持细菌以减少婴儿绞痛 |
| CA3103356A1 (en) * | 2018-07-24 | 2020-01-30 | Biogaia Ab | Therapeutic methods using bacterial strains which are capable of increasing adenosine levels |
| WO2020028871A1 (en) * | 2018-08-03 | 2020-02-06 | Research Institute At Nationwide Children's Hospital | Prenatal probiotic formulations |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| CA3111795A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
| EP3870154A4 (en) | 2018-10-22 | 2022-07-27 | Research Institute at Nationwide Children's Hospital | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ANTIBIOTIC-INDUCED PATHOLOGIES USING PROBIOTICS IN BIOFILM STATE |
| EP3979830B1 (en) | 2019-06-03 | 2025-11-26 | Research Institute at Nationwide Children's Hospital | Formulations for the treatment of neurodevelopmental deficiencies induced by necrotizing enterocolitis |
| CA3238788A1 (en) | 2021-11-22 | 2023-05-25 | Eric Michael Schott | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| WO2023201092A1 (en) * | 2022-04-14 | 2023-10-19 | Washington University | Prevotella copri formulations and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6872565B2 (en) * | 2003-01-29 | 2005-03-29 | Biogaia Ab | Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries |
| SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
| EP2147678A1 (en) * | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
| EP2295535A1 (en) * | 2009-09-11 | 2011-03-16 | Mead Johnson Nutrition Company | Probiotic material |
| EP2609813A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system |
-
2015
- 2015-05-20 MX MX2016015153A patent/MX2016015153A/es unknown
- 2015-05-20 JP JP2016568694A patent/JP2017515881A/ja active Pending
- 2015-05-20 KR KR1020167031451A patent/KR20170005806A/ko not_active Withdrawn
- 2015-05-20 AU AU2015261869A patent/AU2015261869A1/en not_active Abandoned
- 2015-05-20 EP EP15726890.5A patent/EP3145520A2/en not_active Withdrawn
- 2015-05-20 US US15/312,465 patent/US20170216375A1/en not_active Abandoned
- 2015-05-20 CN CN201580025721.0A patent/CN106879253A/zh active Pending
- 2015-05-20 WO PCT/EP2015/061181 patent/WO2015177246A2/en not_active Ceased
-
2016
- 2016-10-27 CL CL2016002732A patent/CL2016002732A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017515881A (ja) | 2017-06-15 |
| WO2015177246A2 (en) | 2015-11-26 |
| US20170216375A1 (en) | 2017-08-03 |
| KR20170005806A (ko) | 2017-01-16 |
| EP3145520A2 (en) | 2017-03-29 |
| WO2015177246A3 (en) | 2016-03-03 |
| WO2015177246A8 (en) | 2016-01-14 |
| CN106879253A (zh) | 2017-06-20 |
| CL2016002732A1 (es) | 2017-04-28 |
| AU2015261869A1 (en) | 2016-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016015153A (es) | Complementacion de microbioma neonatal. | |
| Newaj-Fyzul et al. | Developments in the use of probiotics for disease control in aquaculture | |
| MX2022013835A (es) | Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños en con fines de salud. | |
| Nader-Macías et al. | Profiles and technological requirements of urogenital probiotics | |
| MX2009009318A (es) | Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea. | |
| MY159072A (en) | Probiotics to increase iga secretion in infants born by caesarean section | |
| PH12017502182A1 (en) | Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants | |
| MY166946A (en) | Methods of using human milk oligosaccharides for improving airway respiratory health | |
| PH12014501749A1 (en) | A nutritional composition comprising probiotics and improving sleep patterns | |
| MY169326A (en) | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract | |
| MY191538A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
| MX2010005132A (es) | Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos. | |
| PH12016501974A1 (en) | Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides | |
| MY177636A (en) | Use of lactic acid bacteria to treat or prevent eczema | |
| EA201890223A1 (ru) | Lactobacillus paracasei для продуцирования линолевой кислоты с сопряженными связями, питательные и фармацевтические препараты, содержащие этот штамм, и их применение | |
| NZ712603A (en) | Composition containing bacterium belonging to genus lactobacillus | |
| EP4410298A3 (en) | Therapeutic microvesicles of probiotic bacteria | |
| PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
| MX2019015306A (es) | Probioticos y metodos de uso. | |
| NZ712617A (en) | Bacterium belonging to genus lactobacillus | |
| Namazova-baranova et al. | GUT MICROBIOCENOSIS CORRECTION IN YOUNG INFANTS WITH PERINATAL PATHOLOGY CONSEQUENCES | |
| TH137044A (th) | การผลิตจุลินทรีย์ที่สร้างวิตามินเสริมสุขภาพจากแบคทีเรีย | |
| Zakharova et al. | The role of sour-milk products in nutrition of children | |
| Connoly | For crying out loud... news | |
| MX2016002865A (es) | Nutracéutico para control del síndrome metabólico. |